A detailed history of Bill Few Associates, Inc. transactions in Abbott Laboratories stock. As of the latest transaction made, Bill Few Associates, Inc. holds 36,130 shares of ABT stock, worth $4.3 Million. This represents 1.48% of its overall portfolio holdings.

Number of Shares
36,130
Previous 35,448 1.92%
Holding current value
$4.3 Million
Previous $3.68 Million 11.84%
% of portfolio
1.48%
Previous 1.43%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$100.07 - $118.13 $68,247 - $80,564
682 Added 1.92%
36,130 $4.12 Million
Q2 2024

Jul 16, 2024

BUY
$100.73 - $112.44 $20,448 - $22,825
203 Added 0.58%
35,448 $3.68 Million
Q1 2024

Apr 18, 2024

BUY
$109.52 - $120.96 $13,690 - $15,120
125 Added 0.36%
35,245 $4.01 Million
Q4 2023

Jan 16, 2024

SELL
$90.19 - $110.4 $63,583 - $77,832
-705 Reduced 1.97%
35,120 $3.87 Million
Q3 2023

Oct 20, 2023

BUY
$95.53 - $114.62 $201,950 - $242,306
2,114 Added 6.27%
35,825 $3.47 Million
Q2 2023

Jul 18, 2023

BUY
$100.78 - $112.29 $190,574 - $212,340
1,891 Added 5.94%
33,711 $3.68 Million
Q1 2023

Apr 17, 2023

BUY
$96.86 - $114.01 $33,416 - $39,333
345 Added 1.1%
31,820 $3.22 Million
Q4 2022

Jan 24, 2023

BUY
$95.06 - $111.52 $69,013 - $80,963
726 Added 2.36%
31,475 $0
Q3 2022

Oct 13, 2022

BUY
$96.76 - $112.03 $9,579 - $11,090
99 Added 0.32%
30,749 $2.98 Million
Q2 2022

Jul 26, 2022

BUY
$102.07 - $123.37 $32,356 - $39,108
317 Added 1.05%
30,650 $3.33 Million
Q1 2022

Apr 27, 2022

BUY
$114.02 - $139.04 $17,103 - $20,856
150 Added 0.5%
30,333 $3.59 Million
Q4 2021

Mar 04, 2022

BUY
$115.53 - $141.46 $3.49 Million - $4.27 Million
30,183 New
30,183 $4.25 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Bill Few Associates, Inc. Portfolio

Follow Bill Few Associates, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bill Few Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bill Few Associates, Inc. with notifications on news.